Being able to wake up, see clearly, and enjoy activities like swimming, running, hiking, and traveling has been truly life-changing.
When patients learn that I trusted the LAL for my own eyes, it gives them confidence in their decision. After my surgery, I encouraged my father-in-law to have cataract surgery, and he chose the Light Adjustable Lens as well. Two years later, I’m still very happy with my vision.”
Seeing the outcomes in my own patients made choosing the Light Adjustable Lens an easy decision. What stood out to me personally was the value of being able to fine-tune the result rather than settling. My vision today feels as crisp as it did in my contact lens days. Having gone through it myself, I truly believe we will one day look back and wonder how we accepted non-adjustable lenses.”
I chose the Light Adjustable Lens after seeing the quality of vision my patients were achieving. Being able to test-drive my own vision and guide the decision-making process was incredibly valuable. That experience allows me to confidently tell colleagues and patients that it provides excellent visual quality with minimal compromise.”
As a refractive surgeon, visual quality and precision are my top priorities. I wanted the highest likelihood of achieving accurate, high-quality vision while minimizing residual refractive error, so the Light Adjustable Lens was a natural choice for me. The adjustment process was straightforward and comfortable, and I would make the same choice again.”
When I was choosing my own lens, I asked several surgeons what they would select for themselves, and the overwhelming recommendation was the Light Adjustable Lens. As a surgeon, I understand the limitations of any procedure and how healing can influence the final result, so having the ability to adjust my vision after surgery was a major factor in my decision. That level of precision has left me very satisfied with my outcome.”
As a surgeon, I knew the options well and wanted the most precise, customizable approach available. The ability to experience my vision and refine it without rushing the process was incredibly valuable. Overall, it has been a very satisfying experience.”
I selected the Light Adjustable Lens for my own eyes because it removed uncertainty. Being able to refine my vision after surgery gave me confidence in the process, and today I simply do not think about my vision anymore. Having experienced it myself, I recommend it to patients with complete confidence.”
As a surgeon, I understood the advantages of the Light Adjustable Lens for my own eyes. The ability to adjust and fine-tune my vision gave me tremendous confidence in the process. The extra postoperative time was absolutely worth it. It is remarkable to experience such stable, high-quality vision.”
As surgeons, we know that predicting the exact refractive outcome isn’t always straightforward. Being able to adjust my vision based on real-world experience was incredibly valuable. That flexibility allowed me to land on an outcome that truly suited my visual needs, and I’m very pleased with the quality of my vision.”
The ultimate clinical endorsement: their own eyes.
Because every practice is different—and every patient’s vision matters. Let’s explore what’s measurable for your practice. Fill out the form to connect with a specialist and see how this could work for your practice.
©2026 RxSIGHT. All Rights Reserved. COM-1406 Rev. C
The Light Adjustable Lens provides optimized vision for patient satisfaction.2
Light Adjustable Lens patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).
Since the Light Adjustable Lens is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.
The Light Adjustable Lens offers LASIK-like accuracy in cataract surgery.2,3
92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).
Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.
The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.
The Light Adjustable Lens corrects as low as 0.50 D of astigmatism, which is the lowest level approved to be treated.